Lemaitre Vascular (LMAT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Sales | 66,551 | 64,453 | 61,046 | 64,232 | 59,871 |
| Cost of Goods | 18,155 | 18,263 | 15,091 | 19,258 | 18,451 |
| Gross Profit | 48,396 | 46,190 | 45,955 | 44,974 | 41,420 |
| Operating Expenses | 30,776 | 27,621 | 25,734 | 29,090 | 29,245 |
| Operating Income | 17,775 | 18,832 | 20,312 | 16,142 | 12,626 |
| Interest Expense | 1,300 | 1,298 | 1,297 | 1,299 | 1,290 |
| Other Income | 3,197 | 2,766 | 3,558 | 3,227 | 2,905 |
| Pre-tax Income | 19,672 | 20,300 | 22,573 | 18,070 | 14,241 |
| Income Tax | 3,993 | 4,718 | 5,211 | 4,291 | 3,230 |
| Net Income Continuous | 15,679 | 15,582 | 17,362 | 13,779 | 11,011 |
| Net Income | $15,679 | $15,582 | $17,362 | $13,779 | $11,011 |
| EPS Basic Total Ops | 0.69 | 0.68 | 0.77 | 0.61 | 0.49 |
| EPS Basic Continuous Ops | 0.69 | 0.69 | 0.77 | 0.61 | 0.49 |
| EPS Diluted Total Ops | 0.68 | 0.69 | 0.75 | 0.60 | 0.48 |
| EPS Diluted Continuous Ops | 0.68 | 0.72 | 0.71 | 0.60 | 0.48 |
| EPS Diluted Before Non-Recurring Items | 0.68 | 0.68 | 0.62 | 0.60 | 0.48 |
| EBITDA(a) | $20,620 | $21,657 | $23,578 | $18,578 | $15,390 |